These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2510040)

  • 1. Novel therapy for Alzheimer's disease.
    DeFeudis FV
    Neurobiol Aging; 1989; 10(5):467-8; discussion 477-8. PubMed ID: 2510040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zeroing in on amyloid proteins in Alzheimer disease therapy.
    Festoff BW
    Neurobiol Aging; 1989; 10(5):465-6; discussion 477-8. PubMed ID: 2510039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP processing and the APP-KPI domain involvement in the amyloid cascade.
    Menéndez-González M; Pérez-Pinera P; Martínez-Rivera M; Calatayud MT; Blázquez Menes B
    Neurodegener Dis; 2005; 2(6):277-83. PubMed ID: 16909010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of the amyloid peptide precursor containing the Kunitz protease inhibitor domain improves the inhibition of trypsin.
    Godfroid E; Octave JN
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1015-21. PubMed ID: 2121136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
    Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
    Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta-amyloid in the development of Alzheimer's disease.
    Ii K
    Drugs Aging; 1995 Aug; 7(2):97-109. PubMed ID: 7579788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
    Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
    Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons.
    Caswell MD; Mok SS; Henry A; Cappai R; Klug G; Beyreuther K; Masters CL; Small DH
    Eur J Biochem; 1999 Dec; 266(2):509-16. PubMed ID: 10561592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains.
    Johnson SA; Pasinetti GM; May PC; Ponte PA; Cordell B; Finch CE
    Exp Neurol; 1988 Nov; 102(2):264-8. PubMed ID: 2460367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells.
    Matsumoto A; Fujiwara Y
    Biochem Biophys Res Commun; 1991 Mar; 175(2):361-5. PubMed ID: 1902089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
    Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL
    Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurite outgrowth and the amyloid protein precursor.
    Hammond DN
    Neurobiol Aging; 1989; 10(5):575-6; discussion 588-90. PubMed ID: 2510044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a therapeutic strategy based on amyloid precursor protein: unanswered questions.
    Davis KL
    Neurobiol Aging; 1989; 10(5):475-6; discussion 477-8. PubMed ID: 2510043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor.
    Hynes TR; Randal M; Kennedy LA; Eigenbrot C; Kossiakoff AA
    Biochemistry; 1990 Oct; 29(43):10018-22. PubMed ID: 2125487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focusing on IL-1-promotion of beta-amyloid precursor protein synthesis as an early event in Alzheimer's disease.
    Blume AJ; Vitek MP
    Neurobiol Aging; 1989; 10(5):406-8; discussion 412-4. PubMed ID: 2510037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of the Kunitz protease-inhibitor domain of the beta-amyloid precursor protein.
    Schilling J; Wang Y; Lau K; Smith L; Cordell B
    Gene; 1991 Feb; 98(2):225-30. PubMed ID: 1707846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and cellular localization of amyloid beta-protein precursor transcripts in normal human brain and in Alzheimer's disease.
    Spillantini MG; Hunt SP; Ulrich J; Goedert M
    Brain Res Mol Brain Res; 1989 Nov; 6(2-3):143-50. PubMed ID: 2515408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
    Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
    Panegyres PK; Zafiris-Toufexis K; Kakulas BA
    J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.